Advertisement

Journal of Physiology and Biochemistry

, Volume 57, Issue 2, pp 71–79 | Cite as

Inhibition of intestinal absorption of 5-methyltetrahydrofolate by fluoxetine

  • A. Amilburu
  • I. Idoate
  • F. PonzEmail author
  • J. Larralde
Article
  • 36 Downloads

Abstract

Thein vitro uptake of 5-methyltetrahydrofolate (5-MeTHF) by rat and human intestine is dose-dependently inhibited by the antidepressant drug fluoxetine (FLX). In rat jejunum rings, 0.2 mM FLX inhibited the uptake of 5-MeTHF (0.25 μM) by 32% (15 min) and 49% (45 min). In brush border membrane vesicles (BBMV) from rat jejunum, 0.2 mM FLX inhibited the folate uptake at the overshoot (90 s) by 40 %. Similar inhibition was observed with human Caco-2 cells and duodenal biopsies. FLX action is exerted on the active transport component of the folate uptake, since the drug has no effect when the passive diffusion component becomes prominent by high substrate concentration, or by 0-4 ºC incubation or by addition of the folate transport inhibitor DIDS (1mM). The kinetic analysis with rat BBMV suggests a non-competitive inhibition of the 5-MeTHF transport by FLX, with apparent values for KM = 0.89 μM, Vmax = 1.89 pmol/mg prot./10 s, and KI = 0.21 mM. After 21 days of treatment with FLX (10 mg/kg/day), the folate uptake by jejunum rings or by BBMV from the treated rats was diminished, and the folate levels in erythrocytes and serum were also decreased.

Key words

Folate Intestinal absorption Fluoxetine 

Inhibición de la absorción intestinal de 5-metil-tetrahidrofolato por la fluoxetina

Resumen

La entrada de 5-metil-tetrahidrofolato (5-MeTHF) a los enterocitos de intestino de rata y de humanos in vitro se inhibe por el antidepresivo fluoxetina (FLX) a concentraciones 0,1 mM y superiores. En anillos de yeyuno de rata, FLX 0.2 mM inhibe la entrada de 5-MeTHF (0,25 mM) un 32 % (15 min) y un 49 % (45 min). En vesículas de membrana del borde en cepillo (BBMV) de yeyuno de rata, FLX 0,2mM inhibe un 40 % la incorporación de 5-MeTHF (0,25 mM) en el pico máximo (90 s). Con células humanas Caco-2 y con biopsias duodenales se observaron inhibiciones parecidas. La acción de la FLX se ejerce sobre el componente de transporte activo de la entrada de folato, ya que el fármaco carece de efecto cuando el componente de difusián pasiva se hace muy prominente por alta concentración de substrato, por incubación a 0-4 ºC, o por adición de DIDS 1mM que inhibe el transporte del folato. El análisis cinético con BBMV de rata sugiere que la inhibición del transporte de 5-MeTHF por FLX es de tipo no competitivo, con valores aparentes de KM = 0,89 μM, Vmax = 1,89 pmol/mg prot./10 s, y KI = 0,21 mM. Después de un tratamiento de 21 días con FLX (10 mg/kg/día), la incorporación de folato por anillos de yeyuno o por BBMV de las ratas tratadas está disminuida y los niveles de folato en eritrocitos y suero son también menores.

Palabras clave

Folato Absorción intestinal Fluoxetina 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Altamura, A. C., Moro, A. R., Percudani, M. (1994):Clin. Pharmacokinet.,26, 201–214.CrossRefPubMedGoogle Scholar
  2. 2.
    Beasley, C. M., Masica, D, N. and Potvin, J. H. (1992):Psychopharm. Berl.,107, 1–10.CrossRefGoogle Scholar
  3. 3.
    Bradford, B. B. (1976):Anal. Biochem.,72, 248–254.CrossRefPubMedGoogle Scholar
  4. 4.
    Butteworth, C. E., Santini, R. and Frommeyer, W. B. (1963):J. Clin. Invest.,42, 1929–1939.CrossRefGoogle Scholar
  5. 5.
    Chandler, C. J., Wang, T.T. and Halsted, C. H. (1986):J. Biol. Chem.,261, 928–933.PubMedGoogle Scholar
  6. 6.
    Crane, R. K. and Maldestan, P. (1960):Biochim. Biophys. Acta,45, 460–467.CrossRefPubMedGoogle Scholar
  7. 7.
    Dahlqvist, A. (1984):Anal. Biochem.,7, 18–25.CrossRefGoogle Scholar
  8. 8.
    Dhar, G. H., Selhub, J., Gay, C. and Rosenberg, I. H. (1977):Gastroenterology,72, 1049.Google Scholar
  9. 9.
    Durand, P., Prost, M., Blache, D. (1997):Arterioscler. Thromb. Vasc. Biol.,17, 1939–1946.PubMedGoogle Scholar
  10. 10.
    Durand, P, Prost, M., Blache, D. (1998):Clin. Chem. Lab. Med.,36, 419–429.CrossRefPubMedGoogle Scholar
  11. 11.
    Eli Lilly and Co.,Fluoxetine prescribing information, (1994), Indianapolis.Google Scholar
  12. 12.
    Elsborg, L., Lyngbye, J. and Rittig, K. (1981): In “Folic acid and folic acid deficiency”, A/S Ferrosan, Copenhagen.Google Scholar
  13. 13.
    Fava, M., Borus, J. S., Alpert, J. E., Nierenberg, A. A., Rosenbaum, J. F., Bottiglieri, T. (1997):Am. J. Psychiatry,154, 426–428.PubMedGoogle Scholar
  14. 14.
    Gan, L. S., Hsyu, P. H., Pritchard, J. F., Thakker, D. (1993):Pharm. Res.,10, 1722–1725.CrossRefPubMedGoogle Scholar
  15. 15.
    Goodman and Gilman. (1996): In “Las bases farmacológicas de la terapéutica”, Interamericana, Madrid.Google Scholar
  16. 16.
    Hall, H. M., Pirini, B. B. K. and Campbell, D. (1976):Br. J. Obstet. Gynaecol.,83, 132.PubMedGoogle Scholar
  17. 17.
    Halsted, C. H. (1990): In “Folic acid metabolism in health and disease” (Picciano, M. F., Stockstad, E. L. R. and Gegory, J. F., eds.), Wiley-Lyss, New York, pp. 23–45.Google Scholar
  18. 18.
    Hopfer, U., Nelson, K., Perrotto, J. and Isselbacher, K. J. (1973):J. Biol. Chem.,248, 25–32.PubMedGoogle Scholar
  19. 19.
    Jorgensen, P. L. (1975):Biochim. Biophys. Acta,401, 399–415.CrossRefPubMedGoogle Scholar
  20. 20.
    Kumar, C. K., Moyer, M. P., Dudeja, P. K. and Said, H. M. (1997):J. Biol. Chem.,272, 6226–6231.CrossRefPubMedGoogle Scholar
  21. 21.
    Kumar, C. K., Nguyen, T. T., Gonz’alez, F.B. and Said, H. M. (1998):Am. J. Physiol.,274, 289–294.Google Scholar
  22. 22.
    Mason, J. B. (1990): In “Folic acid metabolism in health and disease” (Picciano, M. F., Stockstad, E. L. R. and Gregory, J. F. eds.), Wiley-Lyss, New York, pp. 47–54.Google Scholar
  23. 23.
    Monteiro, J. B. R., Jordan, J., Barber, A. y Larralde, J. (1993):J. Clin. Nutr. Gastroenterology,8, 13–20.Google Scholar
  24. 24.
    Nguyen, T.T., Dyer, D. L., Dunning D.D., Rubin, S. A., Grant, K, E, Said, H. M. (1997):Gastroenteroloy,112, 783–791.CrossRefGoogle Scholar
  25. 25.
    Pinto, M., Robine-León, S., Appay, M. D., Kedinger, M., Triadou, N., Dussaulx, E., Lacroix, B., Simmon-Assmann, P., Haffen, K., Fogh, J., Zweibaum, A. (1983):Biol. Cell.,47, 323–330.Google Scholar
  26. 26.
    Rosalki, S. B., Foo, A. Y., Burlina, A., Prellwitz, W., Stieber, P., Neumeier, D., Klein, G., Poppe, W. A. and Bodenmuller, H. (1993):Clin. Chem.,39, 648–652.PubMedGoogle Scholar
  27. 27.
    Rosenberg, I. H. (1981): In “Physiology of gastrointestinal tract” (Johnson, L., ed.), Raven Press, New York, pp. 1221–1230.Google Scholar
  28. 28.
    Said, H. M., Ghisan, F. K., Murrell, J. E. (1985):Am. J. Physiol.,249, 567–571.Google Scholar
  29. 29.
    Said, H. M., Ghishan, F. K. and Redha, R. (1987):Am. J. Physiol.,252, G229-G236.PubMedGoogle Scholar
  30. 30.
    Said, H. M., Nguyen, T. T., Dyer, D. L., Cowan, K. H. and Rubin, S. A. (1996):Biochim. Biophys. Acta,1281, 164–172.CrossRefPubMedGoogle Scholar
  31. 31.
    Said, H. M., Ortiz, A., Tapia, A. and Valerio, C. K. (1997):Am. J. Physiol.,272, 729–736.Google Scholar
  32. 32.
    Said, H. M. and Redha, R. (1987):Biochem. J.,247, 141–146.PubMedGoogle Scholar
  33. 33.
    Said, H. M. and Strum, W. B. (1983):J. Pharmacol. Exp. Ther.,226, 95–99.PubMedGoogle Scholar
  34. 34.
    Schron, C. M., Washington, C. and Blitzer, B. L. (1985):J. Clin. Invest.,76, 2030–2033.CrossRefPubMedGoogle Scholar
  35. 35.
    Selhub, J. and Rosenberg, I. H (1981):J. Biol. Chem.,256, 4489–4493.PubMedGoogle Scholar
  36. 36.
    Shirazi-Beechey, S. P., Davies, A. G. and Tebutt, K. (1990):Gastroenterology,98, 676–685.PubMedGoogle Scholar
  37. 37.
    Torania, S. A., Naom, H. F., Said, H. M. and Dudeja, P. K. (1995):Gastroenterology,108, 757.CrossRefGoogle Scholar
  38. 38.
    Urdaneta, E., Idoate, I. and Larralde, J. (1998):Br. J. Nutr.,79, 439–446.CrossRefPubMedGoogle Scholar
  39. 39.
    Van den Berg, H., Finglas, P. M. and Bates, C. (1994):Int. J. Vit. Nutr. Res.,64, 288–293.Google Scholar
  40. 40.
    Webster, S. G. P. and Leaning, J. T. (1979):J. Am. Geriatr. Soc.,27, 451–454.PubMedGoogle Scholar
  41. 41.
    Wong, D. T., Bymaster, F.P. and Engleman, E. A. (1995):Life Sci.,57, 411–441.CrossRefPubMedGoogle Scholar
  42. 42.
    Zimmerman, J. (1990):Gastroenterology,99, 964–972.PubMedGoogle Scholar
  43. 43.
    Zimmerman, J. (1992):Biochem. Pharmacol.,44, 1839–1842.CrossRefPubMedGoogle Scholar

Copyright information

© Universidad de Navarra 2001

Authors and Affiliations

  1. 1.Depto. de Fisiología y Nutrición, Facultad de FarmaciaUniversidad de NavarraNavarraSpain
  2. 2.Departamento de BioquímicaHospital Virgen del CaminoPamplonaSpain

Personalised recommendations